NCT06466096 Correlation Analysis of POD and pNCD in Elderly Patients With Gastrointestinal Neoplasms
| NCT ID | NCT06466096 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Xuanwu Hospital, Beijing |
| Condition | Postoperative Delirium |
| Study Type | OBSERVATIONAL |
| Enrollment | 165 participants |
| Start Date | 2024-10-18 |
| Primary Completion | 2026-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 165 participants in total. It began in 2024-10-18 with a primary completion date of 2026-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective cohort study to explore the differences of serum indicators between elderly gastrointestinal neoplasms patients with postoperative delirium (POD) who either develop or do not develop long-term postoperative neurocognitive disorders (pNCD).
Eligibility Criteria
Inclusion Criteria: * Patients ≥65 years of age who have undergone surgical anesthesia of gastrointestinal neoplasms; Sign informed consent. Exclusion Criteria: * Inability to complete cognitive function assessment; Illiteracy, hearing impairment or visual impairment; He has a history of epilepsy, depression, schizophrenia, Alzheimer's disease and other psychiatric and neurological diseases.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06466096 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, up to 100 Years, studying Postoperative Delirium. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06466096 currently recruiting?
Yes, NCT06466096 is actively recruiting participants. Contact the research team at zhaoalei@sina.com for enrollment information.
Where is the NCT06466096 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06466096 clinical trial?
NCT06466096 is sponsored by Xuanwu Hospital, Beijing. The trial plans to enroll 165 participants.